4th Quarter - Report
MCDERMOTT+ LLC for ROCHE DIAGNOSTICS CORPORATION, INC.
Firm
Income
—
Expenses
—
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Advancing H.R.747 and S.1018, the TEST Act. H.R. 6000, CURES 2.0. H.R.4128 and S.2209, the VALID Act. S.3799, PREVENT Pandemics Act. H.R.2617, the Consolidated Appropriations Act, 2023
Foreign entity interest: The foreign entity identified on Form LD-1 could be affected financially by changes to policy referenced on line 16.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHEL STAUFFER | 2013-2015: Health Policy Director, Rep. Diana DeGette; 2008-2011: Legislative Assistant, Senior Legislative Assistant, Rep. John Tierney |
| ERIC ZIMMERMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.